Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1

被引:253
|
作者
Brems, Hilde [1 ]
Beert, Eline [1 ]
de Ravel, Thomy [1 ]
Legius, Eric [1 ]
机构
[1] Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium
来源
LANCET ONCOLOGY | 2009年 / 10卷 / 05期
关键词
NERVE SHEATH TUMORS; GASTROINTESTINAL STROMAL TUMORS; VON-RECKLINGHAUSENS-DISEASE; SOUTH EAST WALES; NF1; GENE; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; INTERGROUP RHABDOMYOSARCOMA; PILOCYTIC ASTROCYTOMAS; CONSENSUS STATEMENT; RAPAMYCIN PATHWAY;
D O I
10.1016/S1470-2045(09)70033-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neurofibromatosis type 1(NF1) is a familial tumour syndrome. Malignant tumours can arise in the nervous and non-nervous system in either childhood or adulthood, with malignant peripheral nerve sheath tumours being most common. Rhabdomyosarcoma and neuroblastoma are paediatric neoplasms that are more common in children with NF1 than in those without the syndrome. Gastrointestinal stromal tumours, somatostatinomas, breast cancer, and phaeochromocytomas are seen in adults with NF1. Several pathways are thought to be involved in the development of tumours associated with NF1: rat sarcoma viral oncogene homologue (RAS)-mitogen activated protein kinase (MAPK), mammalian target of rapamycin (mTOR), and P21 protein (Cdc42/Rac)-activated kinase 1 (PAK1). New insights into the pathogenesis of these tumours will lead to a better understanding of tumour origin and development and will hopefully allow the discovery of new and specific treatments.
引用
收藏
页码:508 / 515
页数:8
相关论文
共 50 条
  • [31] Pathology/pathogenesis of malignant ovarian tumours
    Vatansever, Dogan
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 5 - 5
  • [33] Neurofibromatosis 2, radiosurgery and malignant nervous system tumours
    Baser, ME
    Evans, DGR
    Jackler, RK
    Sujansky, E
    Rubenstein, A
    [J]. BRITISH JOURNAL OF CANCER, 2000, 82 (04) : 998 - 998
  • [34] A population-based study comparing sporadic malignant nerve sheath tumours to these occurring in association with neurofibromatosis type 1
    McGaughran, J
    Moran, A
    Evans, DGR
    [J]. JOURNAL OF MEDICAL GENETICS, 1997, 34 : 214 - 214
  • [35] Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes
    Lodish, Maya B.
    Stratakis, Constantine A.
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 24 (03) : 439 - 449
  • [36] Radiological manifestations of abdominopelvic nerve tumours seen in neurofibromatosis type 1
    Ozcan, H. N.
    Karcaaltincaba, M.
    Oguz, B.
    Haliloglu, M.
    [J]. CLINICAL RADIOLOGY, 2014, 69 (04) : 431 - 435
  • [37] Multifocal glomus tumours of the fingers in two patients with neurofibromatosis type 1
    De Smet, L.
    Sciot, R.
    Legius, E.
    [J]. JOURNAL OF MEDICAL GENETICS, 2002, 39 (08)
  • [38] Glioneuronal tumours in neurofibromatosis type 1: MRI-pathological study
    Fedi, M
    Mitchell, LA
    Kalnins, RM
    Gutmann, DH
    Perry, A
    Newton, M
    Brodtmann, A
    Berkovic, SF
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2004, 11 (07) : 745 - 747
  • [39] Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1
    Stewart, Douglas R.
    Sloan, Jennifer L.
    Yao, Lawrence
    Mannes, Andrew J.
    Moshyedi, Armin
    Lee, Chyi-Chia Richard
    Sciot, Raf
    De Smet, Luc
    Mautner, Victor-Felix
    Legius, Eric
    [J]. JOURNAL OF MEDICAL GENETICS, 2010, 47 (08) : 525 - 532
  • [40] Pathogenesis and management of type 2 neurofibromatosis
    McCabe, Martin G.
    Evans, Dafydd Gareth
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (03): : 281 - 292